genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Latest
All
More
OMICs
10x Ships First Single Cell GEM-X Assays to Customers
OMICs
10x Defends Patent Litigation Strategy after Criticism from Researchers, Rivals
Drug Discovery
StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug
Drug Discovery
Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary
Artificial Intelligence
Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma
Drug Discovery
89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field
Bioprocessing
Cellares Unveils Clinically-Compliant Cell Therapy Manufacturing Platform
OMICs
NanoString Agrees to be Acquired by Investment Firm for $220M
Drug Discovery
StockWatch: Madrigal Shares Soar as FDA Nears Historic MASH Decision
Artificial Intelligence
With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Drug Discovery
StockWatch: Challengers Take Aim at Lilly, Novo Nordisk
Drug Discovery
Novo Nordisk Expands Boston Area Research and Early Development
Artificial Intelligence
Form Bio’s AI Ensures Gene Therapies Pass Muster, with Ginkgo’s Help
GEN Edge
On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
Artificial Intelligence
StockWatch: Nvidia Shares Leap Again after Reporting Record Revenues
Cancer
Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies
Artificial Intelligence
Insilico Joins Scramble to Treat Solid Tumors by Targeting KIF18A
Drug Discovery
StockWatch: Biogen’s Q4 Results Disappoint Analysts
Drug Discovery
With $170M, BioAge Joins Lilly in Oral, Muscle Preserving Obesity Treatment
Drug Discovery
Gilead to Acquire CymaBay for $4.3B, Adding to Liver Portfolio
Drug Discovery
StockWatch: Lilly’s Weighty Q4 Results Impress Investors, Analysts
Industry News
California Agenda: Keep J.P. Morgan, Compete for Jobs
OMICs
At AGBT, 10x Genomics Launches Next-Generation Single Cell Architecture
Drug Discovery
Ultragenyx’s Gene Therapy Ameliorates Pediatric Neurodegenerative Disorder
Drug Discovery
StockWatch: Alto, Fractyl, FibroBiologics Join Parade of Public Biotechs
OMICs
Wholly Trinity: 10x Genomics Focuses on Three Existing Platforms
Drug Discovery
Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity
Drug Discovery
Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies
Cancer
StockWatch: IPO Revival? CG Oncology, ArriVent Raise a Combined $555M
Genome Editing
GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M Genentech Collaboration
Load more
Scroll Up